P Kala
Overview
Explore the profile of P Kala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sargunaraj A, James J, Kala P, Rani R
Perspect Clin Res
. 2024 Nov;
15(4):215-216.
PMID: 39583925
No abstract available.
2.
Miklovic M, Kala P, Melenovsky V
J Physiol Pharmacol
. 2023 Jul;
74(2).
PMID: 37453090
The pressure-volume (PV) analysis is used for an accurate assessment of load-independent cardiac function and is important for the study of cardiovascular diseases and various therapeutic modalities. PV analysis is...
3.
Koc L, Ondrus T, Fila P, Richter S, Kala P
Bratisl Lek Listy
. 2021 Sep;
122(10):700-707.
PMID: 34570570
Right ventricular involvement (RVMI) is a relatively frequent complication in patients developing ST-elevation acute myocardial infarction. The initial diagnosis is most often established using electrocardiography or echocardiography. The gold standard...
4.
Kala P, Tesar D, Hajek P, Adlova R, Veselka J
Bratisl Lek Listy
. 2020 Jul;
121(8):537-540.
PMID: 32726114
Transcatheter aortic valve implantation (TAVI) is a well-established management option for symptomatic patients with severe aortic stenosis. The minimally invasive transfemoral approach is considered to be superior to non-transfemoral accesses;...
5.
Kala P, cervenka L, Skaroupkova P, Taborsky M, Kompanowska-Jezierska E, Sadowski J
Physiol Res
. 2019 Jun;
68(4):589-601.
PMID: 31177795
We found recently that in Ren-2 transgenic hypertensive rats (TGR) addition of soluble epoxide hydrolase inhibitor (sEHi) to treatment with angiotensin-converting enzyme inhibitor (ACEi), surprisingly, increased the mortality due to...
6.
Kala P, Sedlakova L, Skaroupkova P, Kopkan L, Vanourkova Z, Taborsky M, et al.
Physiol Res
. 2018 Mar;
67(3):401-415.
PMID: 29527914
We showed recently that increasing kidney epoxyeicosatrienoic acids (EETs) by blocking soluble epoxide hydrolase (sEH), an enzyme responsible for EETs degradation, retarded the development of renal dysfunction and progression of...
7.
Vasku A, Bienertova-Vasku J, Parenica J, Pavkova Goldbergova M, Novak J, Chmelikova M, et al.
Physiol Res
. 2015 Feb;
63(Suppl 4):S497-507.
PMID: 25669681
Matrix metalloproteinases (MMPs) as well as their inhibitors (TIMPs) play a crucial role in controlling extracellular matrix turnover and have recently been associated with atherosclerosis, myocardial and vascular injury. Moreover,...
8.
Vytiska M, Kala P, Klabenesova I, Bocek O, Jerabek P, Neugebauer P, et al.
Vnitr Lek
. 2013 May;
54(2):150-5.
PMID: 23687706
Introduction: Increased values ofnatriuretic peptides are considered prognostically significant in normal population with respect to mortality and the incidence of cardiovascular events, regardless of the left ventricular function. The objective...
9.
Helanova K, Parenica J, Jarkovsky J, Dostalova L, Littnerova S, Klabenesova I, et al.
Vnitr Lek
. 2012 May;
58(4):266-72.
PMID: 22559799
Introduction: The annual incidence of out-of-hospital cardiac arrest is around 90-190 cases per 100 000 inhabitants. The limiting factor for further prognosis of patients after out-of-hospital arrest is their neurological...
10.
Sukupova L, Novak L, Kala P, Cervinka P, Stasek J
Radiat Prot Dosimetry
. 2011 Jul;
147(1-2):106-10.
PMID: 21757443
In this study, skin dosimetry of patients undergoing interventional cardiology procedures is presented. Three hospitals were included. Two methods were used for skin dosimetry--radiochromic dosimetry films and reconstruction of skin...